Media Summary: Prof Robert Coleman speaks to ecancer in an online interview for the virtual BGICC 2021 meeting about the Dr. Bhavana Pothuri provides an overview of Filmed on location in Las Vegas during the 21st Annual NOCR Meeting, this webcast is part of a series that provides expert ...

Evolving Medical Treatment In Advanced Recurrent Endometrial Cancer - Detailed Analysis & Overview

Prof Robert Coleman speaks to ecancer in an online interview for the virtual BGICC 2021 meeting about the Dr. Bhavana Pothuri provides an overview of Filmed on location in Las Vegas during the 21st Annual NOCR Meeting, this webcast is part of a series that provides expert ... Part of the webinar "Sex-specific and Sex Differences in Joyce F. Liu, MD, MPH, discusses findings from a phase 2 study with the WEE1 inhibitor adavosertib in patients with This session provides an overview of endometrial and

Adilia Urmancheeva- Oncologist of the Surgical Oncogynecology Department, Leading Researcher of the Scientific Department of ... To access the full CME course associated with this video, please visit: ... Groundbreaking new research could change the standard ... inhibitor called pembrolizumab to standard Domenica Lorusso, MD, PhD, Catholic University of Rome and Fondazione Policlinico Gemelli IRCCS, Rome, Italy, talks on the ...

Photo Gallery

Evolving medical treatment in advanced / recurrent endometrial cancer
Evolving medical treatment in advanced/recurrent endometrial cancer
The evolving standard of care for advanced/recurrent endometrial cancer
Exploring Advanced or Recurrent Endometrial Cancer: Practical Considerations and Future Directions
Advances in Endometrial Cancer Treatment (2025)
Navigating the evolving role of immunotherapy in advanced endometrial carcinoma
Advances in the Management of Cervical and Endometrial carcinoma
Advanced or recurrent endometrial cancer: Molecular classification and treatment decisions
Endometrial Cancer: Latest in Prevention and Treatment: Elisabeth Diver, MD Stanford Medicine
Dr. Liu on Phase 2 Study Results of Adavosertib in Recurrent Uterine Serous Carcinoma
New Treatments for Endometrial and Uterine Cancer (2024)
Current treatment options in advanced/recurrent endometrial cancer
Sponsored
Sponsored
View Detailed Profile
Evolving medical treatment in advanced / recurrent endometrial cancer

Evolving medical treatment in advanced / recurrent endometrial cancer

Evolving medical treatment

Evolving medical treatment in advanced/recurrent endometrial cancer

Evolving medical treatment in advanced/recurrent endometrial cancer

Prof Robert Coleman speaks to ecancer in an online interview for the virtual BGICC 2021 meeting about the

Sponsored
The evolving standard of care for advanced/recurrent endometrial cancer

The evolving standard of care for advanced/recurrent endometrial cancer

Advancing

Exploring Advanced or Recurrent Endometrial Cancer: Practical Considerations and Future Directions

Exploring Advanced or Recurrent Endometrial Cancer: Practical Considerations and Future Directions

Download resources and collect credit: https://www.ceconcepts.com/wcv-130-encore/

Advances in Endometrial Cancer Treatment (2025)

Advances in Endometrial Cancer Treatment (2025)

Dr. Bhavana Pothuri provides an overview of

Sponsored
Navigating the evolving role of immunotherapy in advanced endometrial carcinoma

Navigating the evolving role of immunotherapy in advanced endometrial carcinoma

Updates on Immunotherapy in

Advances in the Management of Cervical and Endometrial carcinoma

Advances in the Management of Cervical and Endometrial carcinoma

Filmed on location in Las Vegas during the 21st Annual NOCR Meeting, this webcast is part of a series that provides expert ...

Advanced or recurrent endometrial cancer: Molecular classification and treatment decisions

Advanced or recurrent endometrial cancer: Molecular classification and treatment decisions

Advanced

Endometrial Cancer: Latest in Prevention and Treatment: Elisabeth Diver, MD Stanford Medicine

Endometrial Cancer: Latest in Prevention and Treatment: Elisabeth Diver, MD Stanford Medicine

Part of the webinar "Sex-specific and Sex Differences in

Dr. Liu on Phase 2 Study Results of Adavosertib in Recurrent Uterine Serous Carcinoma

Dr. Liu on Phase 2 Study Results of Adavosertib in Recurrent Uterine Serous Carcinoma

Joyce F. Liu, MD, MPH, discusses findings from a phase 2 study with the WEE1 inhibitor adavosertib in patients with

New Treatments for Endometrial and Uterine Cancer (2024)

New Treatments for Endometrial and Uterine Cancer (2024)

This session provides an overview of endometrial and

Current treatment options in advanced/recurrent endometrial cancer

Current treatment options in advanced/recurrent endometrial cancer

Current

What developments have there been in endometrial cancer treatment?

What developments have there been in endometrial cancer treatment?

Ilana Cass, MD, Dartmouth-Hitchcock

Drug therapy in advanced and recurrent endometrial cancer (Adilia Urmancheeva)

Drug therapy in advanced and recurrent endometrial cancer (Adilia Urmancheeva)

Adilia Urmancheeva- Oncologist of the Surgical Oncogynecology Department, Leading Researcher of the Scientific Department of ...

Monitoring for an Endometrial Cancer Recurrence

Monitoring for an Endometrial Cancer Recurrence

How are

Treatment of Advanced Endometrial Cancer

Treatment of Advanced Endometrial Cancer

To access the full CME course associated with this video, please visit: ...

Endometrial Cancer / Cancer of the Uterus: What you need to know!

Endometrial Cancer / Cancer of the Uterus: What you need to know!

In this video we discuss the details of

New research could change how endometrial cancer is treated

New research could change how endometrial cancer is treated

Groundbreaking new research could change the standard

Advanced or Recurrent Endometrial Cancer Clinical Trial

Advanced or Recurrent Endometrial Cancer Clinical Trial

... inhibitor called pembrolizumab to standard

Latest developments in immunotherapy for advanced/recurrent endometrial cancer

Latest developments in immunotherapy for advanced/recurrent endometrial cancer

Domenica Lorusso, MD, PhD, Catholic University of Rome and Fondazione Policlinico Gemelli IRCCS, Rome, Italy, talks on the ...